Damora Therapeutics Inc (DMRA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access DMRA Annual Balance Sheets →
The balance sheet data below highlights changes in Damora Therapeutics Inc's financial position over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent540.52
Cash & Short-term Investments540.00
Notes Receivable, Current0.06
Prepaid Expense And Other Assets Current4.61
Total Current Assets543.59
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent0.05
Operating Lease Right Of Use Asset-
Total Assets543.64
Liabilities
Accounts Payable, Current AC3.48
Accrued Liabilities And Other Liabilities8.88
Other Liabilities, Current15.19
Total Current Liabilities27.55
Total Long-term Debt0.00
Other liabilities, Noncurrent0.03
OperatingLeaseLiabilityNoncurrent-
Option Contract Indexed To Equity Settlement Share Fair Value4.98
Total Liabilities27.58
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock931.65
Retained Earnings / Accumulated Deficit-546.32
Accumulated Other Comprehensive Income0.73
Other Equity0.73
Common Stockholder's Equity516.06
Preferred Stockholder's Equity0.00
Non-controlling interests & other0.00
Total Stockholder's Equity516.06
Liabilities & Stockholder's Equity543.64
4 historic quarters locked

Sign in to unlock the full Damora Therapeutics Inc balance sheet history.

About Damora Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-342307

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.